## Abstract ## Objective Although depression is known to be frequently associated with dementia, it is nonetheless underβdiagnosed and underβtreated among this patient population. Its effect on outcome for dementia patients is thought to be substantial, because depression appears to induce higher
In-patient major depression: is rolipram as effective as amitriptyline?
β Scribed by A. I. F. Scott; A. F. Perini; P. A. Shering; L. J. Whalley
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 321 KB
- Volume
- 40
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
β¦ Synopsis
The antidepressant efficacy and adverse-effects of rolipram (a dialkoxyphenyl-2-pyrrolidone) were compared to those of amitriptyline in the treatment of depressive illness requiring hospital admission in a double-blind study. Fifty patients meeting DSM-III criteria for Major Depression whose scores on the Hamilton Rating Scale for Depression (HRSD) remained above 17 after 5 to 7 days on placebo were randomly allocated to either treatment. The rate of recovery in those patients treated by amitriptyline was substantially greater than in those patients treated by rolipram. Twice as many patients dropped out of treatment by rolipram because of lack of efficacy or adverse-effects compared with patients treated by amitriptyline. Rolipram produced fewer adverse-effects attributable to cholinergic blockade, but more nausea. We conclude that amitriptyline is more effective than rolipram in the treatment of depressed hospital in-patients.
π SIMILAR VOLUMES
There is some evidence that major depression is characterized by an activation of the inΒ―ammatory response system (IRS). Activation of the IRS and major depression are accompanied by changes in the erythron, such as a lowered number of red blood cells (RBC), lowered hematocrit (Hct), and hemoglobin